Frisius

Verified siteinfo

The Netherlands Henri Dunantweg 2, 8934 AD Heerenveen, The Netherlands

5 trials recruiting
Pancreatic carcinoma · Arteriosclerosis · Atrial fibrillation
Adults and children

About Specializations

Frisius in Heerenveen, The Netherlands specialises in clinical trials of conditions such as Pancreatic carcinoma, Arteriosclerosis, Atrial fibrillation, Breast cancer stage II, and other specialisations. This site conducts important research.

Main research areas of the site

Ophthalmology

The medical center is at the forefront of ophthalmology, focusing on innovative treatments for visual impairments. The center's research is particularly concentrated on addressing myopia in children, a growing concern worldwide.

Progressive Myopia Management
Visual Health in Pediatrics
Advanced Optical Treatments

By exploring the efficacy of various atropine concentrations, the center aims to enhance therapeutic strategies and improve patient outcomes in pediatric ophthalmology.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Henri Dunantweg 28934 AD HeerenveenThe Netherlands

Open in maps ↗

Recruiting now: 5 trials
Conditions studied: 12
Partner status: Verified site

More sites in Heerenveen The Netherlands

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

11 clinical trials

Atrial fibrillation

Recruiting

Phase 3 Study of Etripamil Nasal Spray Compared with Placebo in Patients with Atrial Fibrillation and Rapid Ventricular Rate

Investigational

Phase 3 Study of Etripamil Nasal Spray Compared with Placebo in Patients with Atrial Fibrillation and Rapid Ventricular Rate

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:Etripamil
Sponsor:Milestone Pharmaceuticals Inc.

Contact Research Centre

Chronic kidney disease+1

Recruiting

A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease

Investigational

A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Sponsor:Eli Lilly & Co.

Contact Research Centre

Polycystic ovarian syndrome

Recruiting

Study on Letrozole and Gonadotropins for Women with Polycystic Ovary Syndrome (PCOS) to Improve Live Birth Rates

Registered drugNo placebo

Study on Letrozole and Gonadotropins for Women with Polycystic Ovary Syndrome (PCOS) to Improve Live Birth Rates

Registered drugNo placebo

The Netherlands

Participants:18–64 years
Substances:Follitropin Alfa
Sponsor:Amsterdam UMC Stichting

Contact Research Centre

Plasma cell myeloma

Recruiting

Study on Treatment-Free Intervals for Newly Diagnosed Multiple Myeloma Patients Using Daratumumab, Lenalidomide, and Dexamethasone

Registered drugNo placebo

Study on Treatment-Free Intervals for Newly Diagnosed Multiple Myeloma Patients Using Daratumumab, Lenalidomide, and Dexamethasone

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Daratumumab
Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Contact Research Centre

Study on the Effects of Baricitinib and Drug Combination for Adults with Severe Community-Acquired Pneumonia, Severe Influenza, or Severe and Moderate COVID-19

Recruiting

Registered drugNo placebo

Study on the Effects of Baricitinib and Drug Combination for Adults with Severe Community-Acquired Pneumonia, Severe Influenza, or Severe and Moderate COVID-19

Registered drugNo placebo

The Netherlands

Participants:0–17 years · 18–64 years · 65+ years
Substances:Amoxicillin Sodium
Sponsor:Universitair Medisch Centrum Utrecht

Contact Research Centre

Pancreatic carcinoma

Not yet recruiting

Study of perioperative versus post-surgery FOLFIRINOX (irinotecan, oxaliplatin, fluorouracil, and folinic acid) treatment in patients with resectable pancreatic cancer

Registered drugNo placebo

Study of perioperative versus post-surgery FOLFIRINOX (irinotecan, oxaliplatin, fluorouracil, and folinic acid) treatment in patients with resectable pancreatic cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Fluorouracil
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Gestational diabetes

Not recruiting

Study on the Effects of Metformin in Pregnant Women with Gestational Diabetes

Registered drugNo placebo

Study on the Effects of Metformin in Pregnant Women with Gestational Diabetes

Registered drugNo placebo

The Netherlands

Participants:0–17 years · 18–64 years
Substances:Metformin Hydrochloride
Sponsor:Bethesda Diabetes Research Center B.V.

Contact Research Centre

Myopia

Not recruiting

Comparison of atropine 0.

Registered drugNo placebo

Comparison of atropine 0.

Registered drugNo placebo

The Netherlands

Participants:0–17 years
Substances:Atropine Sulfate
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Study Comparing Two Treatment Sequences of CDK4/6 Inhibitors (Abemaciclib, Palbociclib, or Ribociclib) in Hormone Receptor Positive Advanced Breast Cancer

Registered drugNo placebo